google_counter
Removal of prostate tumor metastases with a gamma probe (694897) | University Hospital Hamburg-Eppendorf - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li style=\"text-align: justify;\">Medical records<\/li>\n\t<li style=\"text-align: justify;\">PSA blood test<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li style=\"text-align: justify;\">Bone scintigraphy (if available)<\/li>\n\t<li style=\"text-align: justify;\">Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Evaluating the available medical reports<\/li>\n\t<li>General clinical examination<\/li>\n\t<li>Urological examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>Complete blood count<\/li>\n\t\t<li>Biochemical analysis of blood<\/li>\n\t\t<li>Inflammation indicators (CRP, ESR)<\/li>\n\t\t<li>Indicators of blood coagulation<\/li>\n\t\t<li>Tumor markers, PSA<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Ultrasound scan of the urogenital system<\/li>\n\t<li>CT scan\/MRI of the abdomen and pelvis<\/li>\n\t<li>Preoperative care<\/li>\n\t<li>Removal of prostate tumor metastases with a gamma probe<\/li>\n\t<li>Consultations of related specialists<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Control examinations<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded ward<\/li>\n\t<li>Recommendations regarding further treatment<\/li>\n<\/ul>\n<div class=\"program_indications_for_surgery\"><h4>Indications<\/h4><ul>\n\t<li>Confirmed prostate cancer with suspected metastasizing<\/li>\n<\/ul>\n<\/div><div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.<\/p>\n\n<p style=\"text-align:justify\"><strong>On the eve of the intervention<\/strong>, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.<\/p>\n\n<p style=\"text-align:justify\"><strong>Removal of prostate tumor metastases with a gamma probe<\/strong> starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.<\/p>\n\n<p style=\"text-align:justify\">As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.<\/p>\n\n<p style=\"text-align:justify\"><strong>After the completion of the operation<\/strong>, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.<\/p>\n\n<p style=\"text-align:justify\">Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":0,"only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"600042302dbdb.jpg","city":"Hamburg","clinic_site":"https:\/\/www.uke.de\/","department_recommend":"1","country":"Germany","country_id":"1","clinic_name":"University Hospital Hamburg-Eppendorf","cinic_name":"University Hospital Hamburg-Eppendorf","department_id":"1415","duration":"5","direction":"Urology","min_duration":0,"clinic_id":"849","paketPrice":850,"paket":"<ul>\n <li>Interpreter up to 3 hours<\/li>\n <li>Translation of 2 pages<\/li>\n<\/ul>","title":"Removal of prostate tumor metastases with a gamma probe","price":{"val":"0.00","type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":0,"req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"140.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"70.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"9","distance":"7","airport_title":"Hamburg"},{"id":"24","distance":"123","airport_title":"Bremen"},{"id":"8","distance":"282","airport_title":"Berlin"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Removal of prostate tumor metastases with a gamma probe in University Hospital Hamburg-Eppendorf

University Hospital Hamburg-Eppendorf

Hamburg, Germany
Program id # 694897
Doctor photo
Prof. Dr. med. Margit Fisch
Department of Adult and Pediatric Urology
Specialized in: urology

The program includes:

  • Initial presentation in the hospital
  • Clinical history taking
  • Evaluating the available medical reports
  • General clinical examination
  • Urological examination
  • Laboratory tests:
    • Complete blood count
    • Biochemical analysis of blood
    • Inflammation indicators (CRP, ESR)
    • Indicators of blood coagulation
    • Tumor markers, PSA
  • Ultrasound scan of the urogenital system
  • CT scan/MRI of the abdomen and pelvis
  • Preoperative care
  • Removal of prostate tumor metastases with a gamma probe
  • Consultations of related specialists
  • Symptomatic treatment
  • Cost of essential medicines
  • Nursing services
  • Control examinations
  • Stay in the hospital with full board
  • Accommodation in 2-bedded ward
  • Recommendations regarding further treatment

Indications

  • Confirmed prostate cancer with suspected metastasizing

How program is carried out

During the first visit, the physician will conduct a clinical examination and go through the results of the available examinations. After that, you will undergo the necessary additional examination, such as the assessment of liver and kidney function, ultrasound scan of the abdominal and pelvic organs. Based on the results, the physician will determine the number and localization of metastases, and plan the upcoming intervention.

On the eve of the intervention, you will receive an injection of radioactively labeled PSMA. PSMA is the substance that binds to the smallest prostate cancer metastases in the lymph nodes and other tissues. The radioactive label will allow the surgeon to find all the metastases during the operation.

Removal of prostate tumor metastases with a gamma probe starts with general anesthesia. After anesthesia, the surgeon makes small incisions through which he inserts endoscopic instruments, a gamma probe and a video camera into the pelvic cavity and abdominal cavity. The gamma probe detects the lymph nodes affected by metastases by a radioactive label, and the surgeon removes them endoscopically. The video camera continuously transmits a three-dimensional image of the operating field in 12-fold magnification to the monitor.

As the surgeon sees the operating field in multiple magnification, he preserves the nerve endings and large blood vessels. This significantly reduces the surgical risks. The gamma probe, in turn, allows detecting and removing all metastases, which minimizes the risk of prostate cancer recurrence.

After the completion of the operation, you will be transferred back to the ward, under the supervision of the attending physician and nursing staff. Due to the minimal invasiveness of the operation and the short duration of general anesthesia, you will not need to stay in the intensive care unit for a long time.

Finally, the attending physician will evaluate the results of control examinations, schedule the date of discharge from the hospital and give you detailed recommendations for further follow-up and treatment.

Required documents

  • Medical records
  • PSA blood test
  • MRI/CT scan (not older than 3 months)
  • Bone scintigraphy (if available)
  • Biopsy results (if available)

Service

Price from:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Hospital directly:
Saving:
Guarantee BookingHealth Price from:

About the department

According to the Focus magazine, the Department of Adult and Pediatric Urology at the University Hospital Hamburg-Eppendorf ranks among the top German medical facilities specializing in prostate cancer treatment!

The department has all the diagnostic and therapeutic options to provide first-class medical care for patients with diseases of the genitourinary system. The priority focus is reconstructive urology, in particular, the whole range of urethral surgery, procedures for the treatment of urinary incontinence (including artificial sphincter implantation, sling procedures), as well as penile surgery for congenital or acquired malformations, prosthetics in case of erectile dysfunction. The department is headed by Prof. Dr. med. Margit Fisch.

The department’s specialists have extensive experience in the treatment of bladder, kidney, adrenal, testicular and penile cancers. This area is represented by the full spectrum of classical surgery and minimally invasive interventions (including the modern da Vinci robotic system). It should be noted that the department is a leader in the field of minimally invasive surgery in Northern Germany, especially in the field of holmium laser surgery for benign prostatic hyperplasia and laparoscopic kidney surgery. Drug treatment of urinary system cancers is carried out in close cooperation with the Department of Oncology and the Comprehensive Cancer Center Hamburg. Thanks to the excellent medical technical base and the skill of the department’s doctors, patients are guaranteed optimal results even in particularly difficult clinical cases.

Another important department’s focus is pediatric urology. The department is one of the leading and most successful medical institutions in Germany specializing in the treatment of urologic problems in boys, as well as a certified Training Center of the European Society for Pediatric Urology (ESDP).

The service range of the department includes:

  • Plastic reconstructive urology
    • Urethral stenosis surgery
    • All forms of urine diversion
    • Renal pelvis and ureter reconstruction
    • Correction of penile curvature and deformities
  • Urologic oncology
    • Prostate cancer
    • Kidney cancer
    • Bladder cancer
    • Germ cell tumors
    • Urothelial carcinoma
    • Testicular tumors
  • General urology
    • Kidney stone disease
    • Urinary incontinence
    • Benign prostatic hyperplasia
    • Erectile dysfunction and penile curvature
    • Urinary tract infections
    • Urinary tract obstruction
  • Pediatric urology
    • Hydronephrosis
    • Urethral stricture
    • Hypospadias
    • Expansion of the renal pelvis
    • Double kidney
    • Enuresis
    • Urinary incontinence
    • Infectious diseases of the urinary tract
    • Neurogenic bladder dysfunction in case of complex malformations
  • Urinary incontinence treatment
    • TVT and TOT procedures
    • Artificial sphincter implantation (AMS-800)
    • Surgery for incontinence caused by neurological disorders
    • Correction of bladder dysfunction
    • Implantation of special stimulants for proper bladder emptying
  • Minimally invasive surgery
    • Endourological, laparoscopic, retroperitoneoscopic and robot-assisted interventions
    • Nephrectomy
    • Holmium Laser enucleation of the prostate (HoLEP) in case of benign prostatic hyperplasia
    • Transurethral resection for benign prostatic hyperplasia
    • Minimally invasive treatment of stones in the urinary system
  • Other medical services

Curriculum vitae

​Education

  • 1980 - 1986 Study of Medicine at the Saarland University.
  • 05.12.1986 Admission to medical practice.
  • 07.1987 Doctoral degree.

Postdoctoral Training

  • 1987 One-year training in Surgery, St. Teresa Clinic, Luxembourg.
  • 1988 - 02.1992 Department of Urology at the University Hospital Mainz.
  • 02.1992 Board certification.
  • 10.1995 Habilitation: "Optimization of ureterosigmostomy, development of rectosigmoid reservoirs".
  • 03.2005 Extraordinary Professor of the University of Mainz.

Additional Qualifications

  • 1998 Special surgical urology.
  • 2008 Tumor drug therapy.
  • 2008 Andrology.

Professional Career

  • Department of Urology, University Hospital Mainz.
    • 03.1992 - 08.1993 Assistant Physician.
    • 09.1993 - 05.1997 Senior Physician.
    • 06.1997 - 12.1999 Leading Senior Physician.
  • 01.2000 - 05.2001 Head of the Section for Pediatric Urology, Department of Adult and Pediatric Urology at the Asklepios Clinic Harburg.
  • 06.2001 - 12.2001 Acting Head of the Department of Adult and Pediatric Urology at the Asklepios Clinic Harburg.
  • 01.2002 - 11.2008 Chief Physician of the Urologic Center Hamburg (UZH), Department of Adult and Pediatric Urology, Asklepios Clinic Harburg.
  • Since 12.2008 Head of the Department of Adult and Pediatric Urology, University Hospital Hamburg-Eppendorf.

Membership in Professional Societies

  • German Society of Urology (DGU) (2003 - 2008 Board Member, Clerk and Spokesperson).
  • Task Force on Pediatric Urology DGU (Clerk).
  • Professional Association of German Urologists (currently, the 2nd Chairperson).
  • Association of North German Urologists.
  • German-Japanese Society.
  • European Association of Urology (EAU).
  • European Society of Pediatric Urology (ESPU).
  • European Society of Genito-Urinary Reconstructive Surgeons (ESGURS).
  • American Association of Urology (AUA).
  • European Society for Genitourinary Reconstructive Surgeons (GURS) (Board Member, President 2000 - 2001).
  • American Academy of Pediatrics, Section of Urology (AAP).
  • Society for Paediatric Urological Surgeons (SPUS)
  • Société Internationale d'Urologie (SIU).
  • Pan African Urological Association.

Publications, Congresses and Other Activities

  • Publications: more than 270, in more than 94 of them the doctor is the first author.
  • Supervisor for doctoral theses (to date): 23 successfully completed works.
  • Organization of congresses (in total, more than 22). Regular congresses include:
    • Advanced training courses in Pediatric Urology within the framework of training for assistant physicians, together with the Department of Pediatric Urology in Linz (every 2 years).
    • International Meeting on Reconstructive Urology (IMORU).
    • International Meeting on Broadcasting Surgical Operations Live (every 3 years).

Photo of the doctor: (c) Universitätsklinikum Hamburg-Eppendorf (UKE) 


About hospital

According to the Focus magazine, the University Hospital Hamburg-Eppendorf is one of the top ten hospitals in Germany! 

Since its foundation in 1889, the hospital has taken a leading position in the European medical arena, which it still holds today. A highly competent medical team of more than 15,300 employees takes care of the health of patients. Approximately 2,900 of them are physicians and researchers, and more than 3,400 work as nurses and therapists. The hospital has 1,738 beds for inpatient treatment, and many diagnostic and therapeutic services are provided on an outpatient basis. A solid foundation for successful clinical practice in the medical complex is formed by a combination of research achievements with state-of-the-art equipment and the highest professionalism of doctors. In addition, the hospital has a modern and extremely comfortable infrastructure. The most important value for every employee of the University Hospital Hamburg-Eppendorf is the health and well-being of every patient.

The medical facility was the first university hospital in Europe to implement an electronic system for storing patient medical reports. As a result, all diagnostic and treatment protocols are stored electronically. In 2011, the hospital was certified as the first fully digital hospital in Europe.

The hospital represents all areas of modern medicine. The doctors of the healthcare facility have a wealth of theoretical knowledge and vast clinical experience, which allows them to easily cope with the treatment of both common and extremely rare, complex clinical cases. About 550,000 patients are treated here each year, over 450,000 of whom receive outpatient medical care.

An important part of the work of the University Hospital Hamburg-Eppendorf is research activities aimed at developing innovative diagnostic and treatment methods. The main areas of research of the hospital include neurobiology, oncology, cardiovascular research, and research on infectious and inflammatory diseases. Special attention is also given to research in molecular imaging and skeletal biology.

The hospital is distinguished by its first-class level of medical care, which is confirmed by numerous quality certificates of European and international standards: DIN EN IS0 9001 certificate, certificates of the German Cancer Society (DKG) in the treatment of breast cancer, colon cancer, gynecological cancer, prostate cancer, and other oncological diseases, certificate of the German Cardiac Society (DGK) in the treatment of acute coronary syndrome, certificate of the German Spine Society (DWG), and others.

Photo: (с) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Hamburg-Eppendorf live in comfortable single and double rooms designed in bright colors. Each room is equipped with an ensuite bathroom with a toilet and a shower. The standard room includes an automatically adjustable bed, a bedside table, a wardrobe, a table and chairs for receiving visitors, a telephone, a radio and a TV. Also, there is Wi-Fi access.

Meals and Menus

The patient and his accompanying person have a daily choice of three menus. If for any reason you do not eat all the food, you will be offered an individual menu. Please inform the medical staff about your dietary preferences prior to the treatment.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

Religious services are available upon request.

Accompanying person

During the inpatient program, an accompanying person may stay with you in a patient room or hotel of your choice.

Hospital accommodation

During the outpatient program, you may stay in a hotel at the hospital.

Hotel

During the outpatient program, you may stay in a hotel of your choice. Managers will help you choose the most suitable options.

The hospital offers a full range of laboratory tests (general, hormonal, tests for infections, antibodies, tumor markers, etc.), genetic tests, various modifications of ultrasound scans, CT scans, MRI and PET / CT, angiography, myelography, biopsy and other examinations. Treatment with medications, endoscopic and robotic operations, stereotaxic interventions is carried out here, modern types of radiation therapy are also used. The hospital offers patients all the necessary therapeutic techniques.

  • Coiling and clipping of aneurysms of different localizations
  • Transjugular intrahepatic portosystemic shunting in patients with portal hypertension
  • Minimally invasive surgeries (da Vinci)
  • Removal and reconstruction of mammary glands
  • Hyperthermic intraperitoneal chemotherapy (HIPEC)

These are arteriovenous malformations and angiomas, vascular aneurysms, pathologies of the mammary glands, pelvic organ prolapse, urinary incontinence, malignant tumors of various localizations (area of ​​​​special attention is treatment of intestinal cancer), pathologies of liver and pancreas, cataracts and rare ophthalmic pathologies (aphakia, aniridia ), infertility and other diseases.

  • Interventional neuroradiology
  • Mammology
  • Oncology
  • Gastroenterology
  • Surgery

Over 2,900 highly qualified physicians and researchers work at the hospital.